Hyper-CVAD–Based Regimens in Adult Patients With Acute Lymphoblastic Leukemia

Elias J. Jabbour

Hyper-CVAD–Based Regimens in Adult Patients With Acute Lymphoblastic Leukemia

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	547-549
Number of pages	3
Journal	Clinical Advances in Hematology and Oncology
Volume	20
Issue number	9
State	Published - Sep 2022
Externally published	Yes

ASJC Scopus subject areas

Hematology
Oncology

Cite this

@article{cf137931d9cb4b11bbf96a30afb294cd,

title = "Hyper-CVAD–Based Regimens in Adult Patients With Acute Lymphoblastic Leukemia",

author = "Jabbour, {Elias J.}",

note = "Funding Information: Dr Jabbour has received research grants from and has consulted for Amgen, Adaptive Biotechnologies, Pfizer, Genen-tech, AbbVie, Ascentage, BMS, and Takeda.",

year = "2022",

month = sep,

language = "English (US)",

volume = "20",

pages = "547--549",

journal = "Clinical Advances in Hematology and Oncology",

issn = "1543-0790",

publisher = "Millennium Medical Publishing, Inc.",

number = "9",

}

TY - JOUR

T1 - Hyper-CVAD–Based Regimens in Adult Patients With Acute Lymphoblastic Leukemia

AU - Jabbour, Elias J.

N1 - Funding Information: Dr Jabbour has received research grants from and has consulted for Amgen, Adaptive Biotechnologies, Pfizer, Genen-tech, AbbVie, Ascentage, BMS, and Takeda.

PY - 2022/9

Y1 - 2022/9

UR - http://www.scopus.com/inward/record.url?scp=85137996313&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85137996313&partnerID=8YFLogxK

M3 - Comment/debate

C2 - 36125944

AN - SCOPUS:85137996313

SN - 1543-0790

VL - 20

SP - 547

EP - 549

JO - Clinical Advances in Hematology and Oncology

JF - Clinical Advances in Hematology and Oncology

IS - 9

ER -

Hyper-CVAD–Based Regimens in Adult Patients With Acute Lymphoblastic Leukemia

ASJC Scopus subject areas

Other files and links

Cite this